about
Severe MUPS in a sick-listed population: a cross-sectional study on prevalence, recognition, psychiatric co-morbidity and impairment.Sickness absence and full return to work after cancer: 2-year follow-up of register data for different cancer sites.Subjective health complaints in relation to sickness absence.Recurrence of medically certified sickness absence according to diagnosis: a sickness absence register study.Sick-listed employees with severe medically unexplained physical symptoms: burden or routine for the occupational health physician? A cross sectional study.The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge.Recurrence of sickness absence due to common mental disorders.Sickness absence due to depressive symptomsAdherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.Psychosocial work conditions and registered sickness absence: a 3-year prospective cohort study among office employees.Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction.The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients.Identifying workers at risk of sickness absence by questionnaire.The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.Trends in return to work of breast cancer survivors.Job demands and health complaints in white and blue collar workers.What bothers the sick-listed employee with severe MUPS?Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus.Effort-reward imbalance is associated with the frequency of sickness absence among female hospital nurses: a cross-sectional study.Sickness absence due to mental health disorders--a societal perspective.Employees sick-listed with mental disorders: who returns to work and when?Assessment of self-statements in agoraphobic situations construction and psychometric evaluation of the Agoraphobic Self-Statements Questionnaire (ASQ).Occupational rewards relate to sickness absence frequency but not duration.Trends in the incidence of sickness absence due to common mental disorders between 2001 and 2007 in the Netherlands.Which work factors determine job satisfaction?Perceived job demands relate to self-reported health complaints.Frequent and long-term absence as a risk factor for work disability and job termination among employees in the private sector.Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study.Job satisfaction and sickness absence: a questionnaire survey.Parametric hazard rate models for long-term sickness absenceJob demands, health perception and sickness absenceSickness absence and psychosocial work conditions: a multilevel studyReturn to work after early-stage breast cancer: a cohort study into the effects of treatment and cancer-related symptomsSickness absence and return to work rates in women with breast cancerReturn to work following sickness absence due to infectious mononucleosisJob satisfaction and short sickness absence due to the common coldHigher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delayThe effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practiceEarly ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction
P50
Q33516978-BAF2B6C1-5873-495F-B27F-F146A8714CFEQ33645511-73C5D207-A39E-4A46-A976-C6E3AC0403A3Q33698856-F5F58DA9-FAC7-44FF-8A37-9302AF33F38AQ33706660-5F5ACE0F-865C-4991-A974-598BF2ACF6BFQ33741101-60B35969-8521-4F19-A04F-2078BCD0785BQ33920384-961DFBE7-E9F9-4728-A7C0-1604EC58DDE2Q34486789-E3D482E6-EB4D-431D-88CF-44E9117E6741Q36478256-FC91CB64-1B90-4B19-A874-FB8B853DF8E7Q36761902-30A3CF8B-3668-4AAB-BACF-5FA9E5E06740Q37353532-C5E183E2-BC41-49A2-B8EC-2E05A90A71BBQ39117454-51743FF5-372B-424B-8EDD-864D09984DA4Q39438625-98B69E34-ACF1-48D7-88F9-44AF9EE737EAQ40298331-023CB99D-555C-494E-97C2-45D3ECE29341Q42781490-6F41F3E3-A026-4864-8E7B-91559D34CF09Q43051161-57AF4359-A068-49D9-B83B-D16E1F8C04D2Q43961060-B32AD874-44AC-4E1E-8269-4CB8DE26F906Q45152582-7606E60F-1F7B-410E-BC09-CE52BB5442C6Q46798136-6D9F99BB-23D0-48F3-8D4A-2BB0591D90BBQ48111869-2C29F887-CEFF-4F5E-84BB-5808DD900990Q50720950-B767ADAF-25EC-46C6-8B0B-4498F53F16F8Q50755963-C4BE5851-140B-47F1-ACBC-F4EFCCBF3A63Q50764008-EBC428D9-4485-475A-A678-77CFADB17E38Q51064908-E18DC182-20A1-4708-B64B-2376266D7BA5Q51774588-1B0D50ED-C3C1-479C-90B8-4285243A5C88Q51866547-7E92ABCD-E09B-429C-92E5-8F499369FE64Q51887139-E91439F2-5204-485A-9FF2-657E2B2F7DF1Q51896257-6A2DF505-6488-4D08-8B69-0E03D23ED672Q51896947-4B8A5FBF-7DE3-416A-90FF-E5F1614A2567Q53099146-D4C65094-0623-473D-8C6E-B22EDED4D00AQ53131557-E38D2943-8599-46BE-B541-9653C45980C6Q79661587-CA789E1B-5053-4A61-81F1-9670ED7D4F47Q80655819-B655A4CB-ABA8-4723-B9BA-31DA920AD37CQ81433169-412EBE27-8A06-4DC7-A495-4F6B1DCF24BFQ81726492-136C3F67-587F-4C56-831B-CE64D789DD2BQ81972035-131F6A4A-37C5-4CF3-9752-4394F1533657Q84327250-EC47BAB9-4BAF-4CC6-B4D1-8CE01F8B477CQ84457012-D3817EFE-6A9D-4E78-933C-1494DFA7A6EDQ84566442-F4425E53-F65B-4CDA-B2AD-72BAA13DFDD3Q86425354-26DB0411-5F1B-411A-B516-3686DCD72FD0Q88155534-399A8BB2-4F79-43C7-8D8F-BF626C13B759
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Petra C Koopmans
@ast
Petra C Koopmans
@en
Petra C Koopmans
@es
Petra C Koopmans
@nl
Petra C Koopmans
@sl
type
label
Petra C Koopmans
@ast
Petra C Koopmans
@en
Petra C Koopmans
@es
Petra C Koopmans
@nl
Petra C Koopmans
@sl
prefLabel
Petra C Koopmans
@ast
Petra C Koopmans
@en
Petra C Koopmans
@es
Petra C Koopmans
@nl
Petra C Koopmans
@sl
P106
P21
P31
P496
0000-0003-4203-4519